论文部分内容阅读
目的:对左氧氟沙星在盆腔炎患者治疗过程中的应用价值进行研究,并探讨其药理作用。方法:选取104例于该院就诊的盆腔炎患者作为本组研究对象,采取平均分配法将其分为研究组和对照组,每组各52例,对照组52例患者静脉滴注氧氟沙星,研究组52例患者静脉滴注左氧氟沙星。结果:研究组患者的降钙素原、白细胞计数、C反应蛋白以及白细胞介素6等指标均低于对照组(P<0.05);研究组总临床有效率较对照组高(P<0.05)。结论:和氧氟沙星相比,治疗盆腔炎患者应用左氧氟沙星,能够取得更为显著的疗效。
Objective: To study the value of levofloxacin in the treatment of patients with pelvic inflammatory disease and to explore its pharmacological effects. Methods: A total of 104 patients with pelvic inflammatory disease were selected as the study subjects in this study. The patients were divided into study group and control group by average distribution method. Each group had 52 cases. In the control group, 52 patients received intravenous infusion of ofloxacin Star, study group 52 patients intravenous infusion of levofloxacin. Results: The procalcitonin, white blood cell count, C-reactive protein and interleukin-6 in the study group were lower than those in the control group (P <0.05). The total clinical effective rate in the study group was higher than that in the control group (P <0.05) . Conclusion: Compared with ofloxacin, the treatment of patients with pelvic inflammatory disease levofloxacin, can achieve more significant effect.